Sensei Biotherapeutics Claimed Company
We push the boundaries of science and imagination to discover and develop innovative medicines for patients. Sensei biotherapeutics is developing a pipeline of medicines designed to fulfill the substantial potential of the immune system to defeat cancer and other diseases. Sensei stands for teacher. We are teaching the immune system to fight cancer and other diseases. That is our mission. Ours is a collaborative and teaching culture where impassioned people are expected to bring their experience and ideas to the mission to contribute to the greater good. read more
Robert Pierce — Chief Research & Development Officer at Sensei Biotherapeutics
Executive Bio
Dr. Pierce has more than two decades of scientific leadership and experience managing large teams dedicated to translation medicine platforms in academia and industry, particularly in immuno-oncology. Prior to Sensei, he was the Scientific Director of the Immunopathology Lab in the Clinical Research Division at the Fred Hutchinson Cancer Research Center. Dr. Pierce is a board-certified Anatomic Pathologist with a strong academic and industry background in immuno-oncology. While at Merck, Dr. Pierce led a team focused on the development of tissue-based biomarkers for Merck’s anti-PD- 1 therapeutic antibody (pembrolizumab; KEYTRUDA®) and was the medical lead responsible for kicking-off the clinical trials of pembrolizumab in Merkel cell carcinoma (MCC) and cutaneous T cell lymphoma (CTCL). Dr. Pierce received his B.A in philosophy from Yale College, MD from Brown University and Anatomic Residency training at the University of Washington.
Executive Team Culture Ratings from Sensei Biotherapeutics Employees
TOP
10%
Sensei Biotherapeutics' Executive Team scores in the Top 10%
of similar sized companies on Comparably
of similar sized companies on Comparably
Sensei Biotherapeutics' Executive Team at a Glance
Based on 105 ratings, Sensei Biotherapeutics' employees are very satisfied with their Executive Team and give them an “A” or 85/100. On average, Women provided higher ratings for their Executive Team compared to Men. Also, the Finance department thinks more highly of the Executive Team relative to the Engineering department.
Sensei Biotherapeutics' Executive Team ranks in the Top 10% of other companies in Boston and Top 10% of other companies on Comparably that also have 11-50 Employees.
×